| Home | Search | Study Topics | Glossary |
|
|
|
 |
 |
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||
| Sponsors and Collaborators: |
National Center for Research Resources (NCRR) Children's Hospital of Philadelphia |
| Information provided by: | National Center for Research Resources (NCRR) |
| ClinicalTrials.gov Identifier: | NCT00008736 |
Purpose
Serial EGC measurements in premature infants attempting to correlate EGC measurements with signs of feeding intolerance and response to metoclopramide therapy.
| Condition | Intervention | Phase |
|
Infant, Newborn, Diseases |
Drug: metoclopramide |
Phase II |
| MedlinePlus related topics: | Premature Babies |
| Drug Information available for: | Metoclopramide Metoclopramide hydrochloride |
| Study Type: | Interventional |
| Study Design: | Treatment, Non-Randomized |
| Official Title: | Electrogastrography (EGC) in Premature Infants With Feeding Intolerance: The Effect of Metoclopramide |
Eligibility
| Ages Eligible for Study: | up to 1 Month |
| Genders Eligible for Study: | Both |
| Accepts Healthy Volunteers: | Yes |
Inclusion:
Premature infants. Absence of 1) infection, 2) congenital anomalies, 3) growth retardation
Contacts and Locations| United States, Pennsylvania | |||||
| Children's Hospital of Philadelphia | |||||
| Philadelphia, Pennsylvania, United States, 19104 | |||||
| National Center for Research Resources (NCRR) |
| Children's Hospital of Philadelphia |
More Information
| Study ID Numbers: | NCRR-M01RR00240-1724 |
| First Received: | January 16, 2001 |
| Last Updated: | June 23, 2005 |
| ClinicalTrials.gov Identifier: | NCT00008736 |
| Health Authority: | United States: Federal Government |
|
|
|
|
|
